Earnings Call · Q1 FY2025·2025-05-01

Q1 25EPS -3.47%·Rev n/aQ4 24EPS +5.00%·Rev n/aQ3 24EPS -19.73%·Rev n/aQ2 24EPS +41.52%·Rev n/a⚠ consensus missing

ELI LILLY & Co LLY

Mike Czapar — Senior Vice President of Investor Relations

Dave Ricks — Chair and Chief Executive Officer

Lucas Montarce — Chief Financial Officer

Dan Skovronsky — Chief Scientific Officer and President, Lilly Research Laboratories

−11.7%1d on move date−12.4% vs SPY3d−8.6%5d−13.6%

Research tier

Behavioral profile computed for 4 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more LLY calls or request research access.

More LLY calls Browse calls Request research access